PAMCX
Price
$92.50
Change
+$1.01 (+1.10%)
Updated
Jun 18 closing price
Net Assets
22.19B
TAAGX
Price
$19.32
Change
+$0.42 (+2.22%)
Updated
Jun 18 closing price
Net Assets
171M
Interact to see
Advertisement

PAMCX vs TAAGX

PAMCX vs TAAGX Comparison Chart in %
View a ticker or compare two or three
VS
PAMCX vs. TAAGX commentary
Jun 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PAMCX is a Hold and TAAGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PAMCX has more cash in the bank: 22.2B vs. TAAGX (171M). PAMCX (0.00) and TAAGX (0.00) have matching dividends . PAMCX was incepted earlier than TAAGX: PAMCX (26 years) vs TAAGX (26 years). TAAGX (1.71) is less costly to investors than PAMCX (1.02). TAAGX is a more actively managed with annual turnover of: 74.00 vs. PAMCX (31.50). TAAGX has a lower initial minimum investment than PAMCX: TAAGX (1000) vs PAMCX (2500). TAAGX annual gain was more profitable for investors over the last year : 57.37 vs. PAMCX (-0.88). TAAGX return over 5 years is better than : 58.74 vs. PAMCX (-21.14).
PAMCXTAAGXPAMCX / TAAGX
Total Expense Ratio1.021.6163%
Annual Report Gross Expense Ratio1.021.7160%
Fund Existence26 years26 years-
Gain YTD0.51636.7581%
Front LoadN/A6%-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets22.2B171M12,982%
Annual Yield % from dividends0.000.00-
Returns for 1 year-0.8857.37-2%
Returns for 3 years-2.8489.76-3%
Returns for 5 years-21.1458.74-36%
Returns for 10 years27.26188.2514%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ETCHX44.110.68
+1.57%
Eventide Healthcare & Life Sciences C
VMNFX15.820.06
+0.38%
Vanguard Market Neutral Inv
NZDCNY3.90-0.04
-0.98%
New Zealand Dollar - China Yuan
IVGAX21.15-0.31
-1.44%
VY® Invesco Growth and Income A
DFVEX33.99-0.51
-1.48%
DFA US Vector Equity I